构象锁定HIV-1融合抑制剂的合成及抗HIV-1活性研究

doi:10.6023/cjoc201710033

有机化学 ›› 2018, Vol. 38 ›› Issue (5): 1267-1270.DOI: 10.6023/cjoc201710033 上一篇下一篇

研究简报

构象锁定HIV-1融合抑制剂的合成及抗HIV-1活性研究

郭叶^a, 傅莉莉^b, 范晓文^a, 史宣玲^b

a 包头医学院药学院包头 014060;
b 清华大学医学院艾滋病综合研究中心北京 100084

收稿日期:2017-10-25 修回日期:2018-01-08 发布日期:2018-01-18
通讯作者: 史宣玲,E-mail:shixuanlingsk@mail.tsinghua.edu.cn E-mail:shixuanlingsk@mail.tsinghua.edu.cn
基金资助:
国家自然科学基金（No.21602121）、内蒙古自然科学基金（No.2016BS0201）和包头医学院博士科学基金（No.BSJJ201620）资助项目.

Synthesis and Anti-HIV-1 Activity of Stapled HIV-1 Fusion Inhibitors

Guo Ye^a, Fu Lili^b, Fan Xiaowen^a, Shi Xuanling^b

a School of Pharmacy, Baotou Medical College, Baotou 014060;
b Comprehensive AIDS Research Center, School of Medicine, Tsinghua University, Beijing 100084

Received:2017-10-25 Revised:2018-01-08 Published:2018-01-18
Contact: 10.6023/cjoc201710033 E-mail:shixuanlingsk@mail.tsinghua.edu.cn
Supported by:
Project supported by the National Natural Science Foundation of China (No. 21602121), the Natural Science Foundation of Inner Mongolia (No. 2016BS0201) and the Doctoral Science Foundation of Baotou Medical College (No. BSJJ201620).

文章分享

摘要/Abstract

西夫韦肽（SFT）是一种有效抗HIV-1（Human Immunodeficiency Virus-1）融合抑制剂，它比已上市融合抑制药物T20拥有更高的药效及药代稳定性，目前已完成了Ⅱb临床实验.以西夫韦肽为模板，通过构象锁定策略将多肽中原有的盐桥替换为共价键合成了SFT订书肽SFT-1和SFT-2.产物结构经圆二光谱确认形成了α-螺旋.对所有合成多肽进行了抗HIV-1活性检测，结果表明SFT订书肽对7个HIV-1假病毒株抑制活性均高于SFT，其中SFT-1对B'亚型和B'C重组亚型病毒株抑制活性最高，SFT-2对B、CRF01_AE和CRF08_BC亚型病毒株抑制活性最高.

关键词: 西夫韦肽, HIV融合抑制剂, 构象锁定, 抗HIV-1活性

Sifuvirtide (SFT) is a potent anti-HIV-1 (human immunodeficiency virus-1) fusion inhibitor and it shows higher potency and pharmacokinetic stability than the approved fusion inhibitor T20. At present, sifuvirtide has completed the phase Ⅱb clinical trial in China. In this study, SFT-1 and SFT-2 were synthesized via all-hydrocarbon cross-linking system with replacing the original salt bridge in SFT by hydrocarbon covalent bond, using sifuvirtide as template. The anti-HIV-1 activity was evaluated for all synthetic peptides. The results indicated that SFT stapled peptides displayed high inhibitory activity against seven HIV-1 pseudovirus strains, and SFT-1 showed the highest inhibitory activity against B' and B'C subtype virus strains, SFT-2 showed the highest inhibitory activity against B, CRF01_AE and CRF08_BC subtype virus strains.

Key words: sifuvirtide, HIV-1 fusion inhibitor, hydrocarbon stapling, anti-HIV-1 activity

引用此文

郭叶, 傅莉莉, 范晓文, 史宣玲. 构象锁定HIV-1融合抑制剂的合成及抗HIV-1活性研究[J]. 有机化学, 2018, 38(5): 1267-1270.

Guo Ye, Fu Lili, Fan Xiaowen, Shi Xuanling. Synthesis and Anti-HIV-1 Activity of Stapled HIV-1 Fusion Inhibitors[J]. Chin. J. Org. Chem., 2018, 38(5): 1267-1270.

导出引用 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

分享此文

参考文献

[1] Dai, S. J.; Dou, G. F.; Qiang, X. H.; Song, H. F.; Tang, Z. M.; Liu, D. S.; Liu, X. W.; Yang, L. M.; Zheng, Y. T.; Liang, Q. Acta Pharmacol. Sin. 2005, 26, 1274.
[2] He, Y.; Xiao, Y.; Song, H.; Liang, Q.; Ju, D.; Chen, X.; Lu, H.; Jing, W.; Jiang, S.; Zhang, L. J. Biol. Chem. 2008, 283, 11126.
[3] Tan, J. J.; Ma, X. T.; Liu, C.; Zhang, X. Y.; Wang, C. X. Curr. Pharm. Des. 2013, 19, 1810.
[4] Tennyson, R. L.; Walker, S. N.; Ikeda, T.; Harris, R. S.; Kennan, A. J.; McNaughton, B. R. ChemBioChem 2016, 17, 1945.
[5] Zhang, D.; Li, W.; Jiang, S. Expert. Opin. Ther. Pat. 2015, 25, 159.
[6] Yu, F.; Lu, L.; Du, L. Y.; Zhu, X. J.; Debnath, A. K.; Jiang, S. B. Viruses 2013, 5, 127.
[7] Yao, X.; Chong, H.; Zhang, C.; Waltersperger, S.; Wang, M.; Cui, S.; He, Y. J. Biol. Chem. 2012, 287, 6788.
[8] Schafmeister, C. E.; Po, J.; Verdine, G. L. J. Am. Chem. Soc. 2000, 122, 5891.
[9] Wachter, F.; Morgan, A. M.; Godes, M.; Mourtada, R.; Bird, G. H.; Walensky, L. D. Oncogene 2017, 36, 2184.
[10] Bird, G. H.; Mazzola, E.; Opoku-Nsiah, K.; Lammert, M. A.; Godes, M.; Neuberg, D. S.; Walensky, L. D. Nat. Chem. Biol. 2016, 12, 845.
[11] Gao, S.; Guo, Y.; Li, H. Y.; Fang, G. M. Prog. Chem. 2014, 26, 100(in Chinese). (高帅, 郭叶, 李海燕, 方葛敏, 化学进展, 2014, 26, 100.)
[12] Hu, X.; He, Y.; Wu, L.; Hao, Y.; Wang, Z.; Zheng, W. Bioorg. Med. Chem. Lett. 2017, 27, 5446.
[13] Cui, H. K.; Qing, J.; Guo, Y.; Wang, Y. J.; Cui, L. J.; He, T. H.; Zhang, L. Q.; Liu, L. Bioorg. Med. Chem. 2013, 21, 3547.
[14] Cui, H. K.; Zhao, B.; Li, Y.; Guo, Y.; Hu, H.; Liu, L.; Chen, Y. G. Cell Res. 2013, 23, 581.
[15] Lau, Y. H.; de Andrade, P.; Wu, Y.; Spring, D. R. Chem. Soc. Rev. 2015, 44, 91.
[16] Keeling, K. L.; Cho, O.; Scanlon, D. B.; Booker, G. W.; Abell, A. D.; Wegener, K. L. Org. Biomol. Chem. 2016, 14, 9731
[17] Wang, D. Y.; Chen, K.; Kulp Ⅲ, J. L.; Arora, P. S. J. Am. Chem. Soc. 2006, 128, 9248.
[18] Fang, G. M.; Wang, J.-X.; Liu, L. Angew. Chem., Int. Ed. 2012, 51, 10347.
[19] Fang, G. M.; Li, Y. M.; Shen, F.; Huang, Y. C.; Li, J. B.; Lin, Y.; Cui, H. K.; Liu, L. Angew. Chem., Int. Ed. 2011, 50, 7645.
[20] Zheng, J. S.; Tang, S.; Qi, Y. K.; Wang, Z. P.; Liu, L. Nat. Protoc. 2013, 8, 2483.

构象锁定HIV-1融合抑制剂的合成及抗HIV-1活性研究

Synthesis and Anti-HIV-1 Activity of Stapled HIV-1 Fusion Inhibitors

PDF

可视化

摘要/Abstract

引用此文

分享此文

参考文献

相关文章 2

编辑推荐

相关统计

本文评价

[1]	王金艳, 董黎颖, 刘雅妮, 陈西同, 马艳楠, 尹昊, 杜姗姗, 齐昀坤, 王克威. 蜈蚣毒素多肽RhTx的高效化学合成及复性折叠研究[J]. 有机化学, 2021, 41(7): 2800-2809.
[2]	赵冕, 蔡乐, 何健民, 尹田鹏, 隋迎春, 罗梦婷, 丁中涛. 棠梨枝叶的化学成分研究[J]. 有机化学, 2013, 33(06): 1284-1290.